Archive · 28 Aug 2026
Symbiotec Pharmalab IPO Allotment Likely Finalised Today
Symbiotec Pharmalab offered shares to the public through an IPO.
Many investors applied, so the issue was subscribed 71.26 times.
This means investors requested far more shares than were available.
The allotment, which shows who received shares, is expected to be finalised on Friday, 28 August.
Investors can check their results online using their PAN, application number, or Demat account number.
They can use the MUFG Intime India, BSE, or NSE website.
The shares are expected to start trading on 1 September 2026.
The grey market is indicating a possible premium, but this is not a guaranteed listing price.
Symbiotec Pharmalab IPO allotment is expected to be finalised on Friday, 28 August.
The IPO was subscribed 71.26 times overall, led by QIB demand of 172.03 times.
NII and retail portions were subscribed 73.63 times and 12.96 times, respectively.
The grey-market premium was reported at ₹270, implying an estimated ₹1,258 listing price.
Applicants can check allotment status through MUFG Intime India, BSE, or NSE websites.
- Who
- Symbiotec Pharmalab and investors who applied for its IPO.
- What
- The IPO allotment is expected to be finalised, with status available online.
- When
- Allotment is expected on Friday, 28 August; the shares are expected to list on 1 September 2026.
- Where
- Allotment status can be checked on the MUFG Intime India, BSE, or NSE websites.
- Why
- The allotment follows the IPO's closure after strong investor demand and the T+3 listing requirement.
- Overall subscription
- 71.26 times
- QIB subscription
- 172.03 times
- NII subscription
- 73.63 times
- Retail subscription
- 12.96 times
- Grey-market premium
- ₹270, according to Investorgain
- Estimated listing price
- ₹1,258, or 27.33% above the IPO price
- IPO price
- ₹988
- Expected listing date
- 1 September 2026